PerkinElmer and IDBS Announce Software Collaboration for Drug Discovery Research
News Jan 08, 2009
IDBS has announced a collaboration with PerkinElmer, Inc. at the 6th Annual High Content Analysis Conference in San Francisco.
The collaboration will be focused on improving data analysis and interpretation of High Content Screening (HCS), an enabling technology in the search for key cellular markers associated with human health and disease.
The collaboration features the integration of PerkinElmer’s Columbus™ image data management system for HCS with IDBS’s ActivityBase XE screening data management software.
The collaboration will provide researchers with a unified interface to access both Columbus’s image data storage capabilities and ActivityBase XE’s screening data analysis and interpretation features, to enable compelling exploratory outcomes in HCS and cellular analysis.
“The future of High Content Screening lies in an increased synergy between technologies that integrate vast image content with large compound sets, to generate actionable research data,” said Richard M. Eglen, Ph.D., president, Bio-discovery, PerkinElmer. “We feel this collaboration with IDBS is a timely and highly promising advance in giving researchers access to greater insights into the cell-based mechanisms of disease, as well as development of novel therapies based on greater understanding of the origins of diseases.”
Neil Kipling, CEO of IDBS, said “ActivityBase XE maintains IDBS’s leading position in data management for the global drug discovery industry, offering innovation and scalable functionality to screening groups worldwide. This new relationship with PerkinElmer provides scientists with the high performance data management tools necessary to maximize the promise which this technical innovation presents.”
PerkinElmer’s Columbus software is a flexible solution for high volume image storage and management. Designed as a partner product for the Opera™ system, PerkinElmer's confocal microplate imaging reader, the software has the added benefit of full compatibility with a wide range of image file formats.
IDBS’s ActivityBase XE delivers ultra high performance data analysis, flexible data visualization/interpretation and storage in one working environment. The new features in ActivityBase XE enable users to analyze rich, multivariant data, perform curve fitting and complex statistics within each well of a MTS, HTS or uHTS experiment.
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Rapid Test Helps with Administering the "Correct" DrugNews
In just three hours, a new rapid test will give information on which available antibiotic is still effective in a concrete case.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018